EW vs PRME · P/E 47, rev $1.39B vs rev $3.0M
Edwards Lifesciences Corp (EW) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PRME currently screens at market cap $570.8M.
Not investment advice. Open the EW and PRME stock pages for the full models.
Not investment advice.